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Abstract. – OBJECTIVE: Chronic rhinosinus-
itis (CRS) of the frontal sinus is a complex 
pathological condition and many surgical tech-
niques were described to treat this area endo-
scopically, like traditional endoscopic sinus sur-
gery (ESS) and balloon catheter dilation (BCD).
PATIENTS AND METHODS: We designed a 
multicenter prospective randomized study to 
assess the validity and safety of BCD vs. ESS in 
symptomatological chronic rhinosinusitis of the 
frontal sinus enrolling a population of 102 adult 
patients (64 men and 38 women; overall 148 
frontal sinuses studied) with non-polypoid CRS. 
For a better evaluation of the disease, in our 
study we decided to analyze both radiological 
(Lund-McKay CT scoring modified by Zinreich) 
and symptomatological results (SNOT-20 ques-
tionnaire). We divided the population affected 
in two groups, one with light/mild frontal CRS 
and the other with moderate/severe frontal CRS, 
basing on radiological findings at Lund-MacK-
ay modified by Zinreich score. Every group was 
divided in two subgroups, in one we used BCD 
and in the other we used traditional ESS.
RESULTS: The current literature does not sup-
port the suggestion that indications for BCD 
and ESS are identical, and additional research 
is needed to determine the role for BCD in spe-
cific patient populations. The results showed 
a not statistically significative difference be-
tween BCD and conventional ESS of the frontal 
sinus in patients with light/mild CRS and in pa-
tients with moderate/severe CRS at Lund-Mack-
ay modified by Zinreich score. The same not sta-
tistically significative difference was observed 
comparing the results of SNOT-20 questionnaire 
in the group of light/mild frontal chronic rhinosi-
nusitis. However, we noticed a statistically sig-
nificant better outcome of SNOT-20 score in pa-
tients with moderate/severe chronic rhinosinus-
itis that underwent BCD of frontal sinus com-
pared to ESS.
CONCLUSIONS: BCD and ESS are two alter-
native weapons in the baggage of every endo-
scopic surgeon, even because they present sim-
ilar outcomes, safeness and effectiveness both 
in light/mild and moderate/severe chronic rhi-
nosinusitis of the frontal sinus. An interesting 
result of our study was the statistically signif-
icant better outcome of SNOT-20 score in pa-
tients that underwent BCD of frontal sinus for a 
moderate/severe CRS, compared to those that 
underwent a traditional ESS.
Key Words:
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Introduction
Chronic rhinosinusitis (CRS) is a common 
disease with a prevalence between 5% and 15% 
of the population and it has a considerable impact 
on quality of life, schooling, work, and ultimately, 
health spending1.
Medical therapy is mainly based on the admin-
istration of topical or systemic antinflammatory, 
corticosteroids and antibiotics, but when it is no 
longer capable of treating pathology, surgical 
therapy becomes necessary2. 
CRS of the frontal sinus is a challenging, con-
stantly evolving and extremely controversial con-
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dition and is usually associated with high long-
term revision rates (10% to 20% of patients), in-
dependently to the approach2-5; during the years, 
many surgical techniques have been described 
to treat this area endoscopically6,7 and usually, 
endoscopic approach may be performed with the 
preservation of the structure and the function of 
the sinus through functional endoscopic sinus 
surgery (ESS or FESS). In effect, it is well known 
that ESS produces significant and durable im-
provement in all the subjective measures of nasal 
airflow and all the sinusitis symptoms8.
Paranasal sinus balloon catheter dilation (BCD) 
represents a quite recent possibility of intervention 
in the management of CRS. BCD is a minimally 
invasive procedure, which seeks to restore physio-
logical sinus drainage through microfractures, so 
as to prevent abnormal scarring associated with 
mucosal stripping9. The current literature suggests 
that can safely dilate the frontal, sphenoid and 
maxillary sinuses with ostial patency in a large 
number of cases for up to two years.
Currently, there are four companies with U.S. 
Food and Drug Administration (FDA)-cleared 
balloon dilation systems: Acclarent* (Menlo 
Park, CA, USA), Entellus Medical* (Plymouth, 
MN, USA), Ventera* (Reston, VA, USA), and 
Medtronic* (Dublin, Ireland).
The purpose of this study was to evaluate the ef-
fectiveness, safety, and correct indication of BCD 
of the frontal recess in the management of CRS of 
the frontal sinus vs. traditional ESS, trying to es-
tablish the role that this surgical technique should 
play in the management of frontal CRS.
Patients and Methods
We designed a multicenter (Policlinico Um-
berto I, Rome, Italy; Bassini Hospital, Milan, 
Italy; Niguarda Hospital, Milan, Italy) prospec-
tive randomized study to assess the validity and 
safety of BCD in symptomatological CRS of the 
frontal sinus vs. traditional endoscopic surgical 
treatment (ESS).
Following the institutional approval of the pro-
tocol and after obtaining an informed consent, 
a population of 102 adult patients (64 men and 
38 women; overall 148 frontal sinuses studied) 
with non-polypoid CRS (according to the criteria 
defined by the European Position Paper on Rhi-
nosinusitis and nasal Polyps Group. 2012) were 
enrolled. The patients were recruited from the 
day hospital of the 3 different facilities; at the 
time of surgery, the subjects were aged between 
17 and 57 years (mean 42 years). All patients were 
studied prior to surgery by collection of medical 
history data, followed by otorhinolaryngologic 
examination, the SNOT-20 subjective symptom-
atological test10, the endoscopic examination of 
nasal cavity and CT in axial, coronal and sagittal 
planes of paranasal sinuses. The degree of every 
frontal sinus involvement at CT was evaluated 
using the Lund-MacKay score system modified 
by Zinreich11 (Table I). 
For a better evaluation of the disease, in our 
study we decided to analyze both radiological 
(modified Lund-McKay CT scoring) and symp-
tomatological results (SNOT-20 questionnaire). 
We added SNOT-20 to the evaluation because, 
although CT scoring are objective metrics, it is 
well known that often they do not correlate well 
with rhinologic symptoms12.
All patients had been subjected to medical 
therapy (antibiotics, corticosteroids and nasal ir-
rigations with saline solution) for at least two 
months, in accordance with EPOS guidelines, 
and had not shown improved evaluation criteria. 
At the end of the cycle of therapy, they were 
thus considered as “non-responders” and were 
referred to surgery.
Exclusion criteria of our study were: pregnan-
cy, previous sinus surgery, cystic fibrosis, para-
nasal sinus tumors, allergy to NSAIDs, coagu-
lopathy, use of anticoagulants, osteoneogenesis or 
Paget’s disease, a previous glaucoma diagnosis, 
and history of facial trauma with distorted sinus 
anatomy.
Informed consent was obtained prior to sur-
gery from designated research staff. The Ethical 
Committee approval was grant by “Sapienza Uni-
versity”, (Rome, Italy)
We studied every patient before any surgical 
treatment with a pre-operative TC and a SNOT-20 
Table I. Zinreich staging system.
 Right Left
Maxillary Maxillary
Anterior ethmoid Anterior ethmoid
Posterior ethmoid Posterior ethmoid
Sphenoid Sphenoid
Frontal Frontal
Osteomeatal complex Osteomeatal complex
Total (maximum = 54)
Zinreich Staging System (Modification of Lund-Mackay). 
Scores Each Sinus 0-5, OMC 0-2. 0 = 0%, 1 = 1-25%, 2 = 
26-50%, 3 = 51-75%, 4 = 76-99%, 5 =100%.
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questionnaire, and divided our population in two 
main groups using the modified Lund-MacKay 
score system:
•  Group “L” (light) included all patients with 
a light/mild involvement of the frontal sinus 
(appreciated with a lower score (1-2) of Zinre-
ich classification) (71 patients/115 pathological 
frontal sinuses);
•  Group “S” (severe) included all patients with 
a moderate/severe involvement of the frontal 
sinus (appreciated with an higher score (3-4-
5) of Zinreich classification) (31 patients/33 
pathological frontal sinuses).
•  At this point, patients of the “L” group were 
randomly allocated creating the subgroups:
•  AL, in which frontal sinus dilatation with BCD 
was performed (composed of 50 frontal sinus-
es);
•  BL, in which traditional endoscopic surgery of 
the frontal recess (ESS) according to the Draf 
1 procedure was performed (composed of 65 
frontal sinuses).
•  The same was realized for patients of the “S” 
group, creating the subgroups:
•  AS, in which frontal sinus dilatation with BCD 
was performed (composed of 19 frontal sinus-
es);
•  BS, in which traditional surgery of the frontal 
recess (ESS) according to the Draf 1 procedure 
was performed (composed of 14 frontal sinuses).
There was homogeneity in primary outcome 
measures (SNOT-20 and Lund-Mackay) between 
the groups.
Anyway, with the patient under general anes-
thesia, ESS was performed for each individual 
case according to the surgical need of the patient. 
So, septoplasty and/or partial middle turbinec-
tomy were performed to increase access to the 
frontal sinus outflow.
Patients who had been assigned to balloon di-
lation of the frontal sinus (subgroups AL and AS) 
were treated with a 5x16 mm Relieva* sinus cath-
eter (Acclarent), inflated at 14 atm for 10 s, and 
positionated following the axilla of the middle 
turbinate under fluoroscopic control13,14. If nec-
essary, serial balloon dilations were performed 
to ensure that the frontal sinus outflow tract was 
completely dilated in its entire length. A 30° and 
45° endoscope was then used to inspect the fron-
tal recess and confirm successful dilation.
In contrast, patients who had been assigned 
to conventional frontal sinus drainage surgery 
(subgroups BL and BS) were treated with a Draf 
I until the frontal sinus ostium was well visual-
ized with the 30° and 45° endoscope. If needed, 
the dissection included removal of the superior 
articulation of the uncinate process, the superior 
aspect of the ethmoid bulla, and the agger nasi 
cell, as well as any frontal cells that may have 
been present (Draf IIa).
In both groups, standard postoperative therapy 
was administered, which comprised antibiotics 
and oral steroids, nasal irrigations and topical 
steroids for 1 month. Nasal aspiration for the 
removal of secretions and scabs was performed 
every week, according to need.
A new nasal endoscopy was performed after 
1 week, 2 weeks, 1 month, 3 months, 6 and 12 
months following surgery by the same surgeon.
Endoscopic assessment was performed using 
direct visualization with a 30° and 70° endoscope 
and patency of the frontal sinus ostia was con-
firmed. A 2 mm outer diameter curved suction 
was also passed into the frontal sinus ostia to 
confirm patency.
If there was edema, the 2-mm-diameter suc-
tion was not pushed through the edema, but the 
patency of the frontal sinus ostium was mea-
sured. If edema was fully obstructing the ostium, 
this was recorded as not patent.
So, we define the permeability of the frontal 
recess as a dichotomous variable (yes/no) before 
surgery and 12 months after surgery.
12 months after surgery, nasal symptoms were 
reassessed (SNOT-20), and a new tomographic 
scan was performed after 1 year to evaluate the 
disease according to the CT Lund-Mackay stage 
system modified by Zinreich, specifically applied 
to the frontal sinus11. The main outcome measure 
was resolution of frontal sinus disease shown on 
CT scan after 12 months follow-up and improve-
ment of symptoms evaluated with SNOT-20 scale.
Some studies have shown that a new stenosis of 
the frontal sinus occurs within 12 months15, so we 
planned the follow-up at 12 months. Effectively, 
after that time, the frontal sinus achieves a good 
reepithelization, with a very low risk of restenosis 
and thus a great likelihood of permanent results.
Statistical Analysis
Statistical analysis was realized with Statistica 
10. Data distribution was tested by Kolmogor-
ov-Smirnov test. Statistical analysis was per-
formed with 2 × 2 ANOVA for repeated measures 
by comparing baseline and post-treatment values 
in the two groups of patients. The post-hoc test 
was done with the SNK test; p < 0.05 was con-
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sidered statistically significant. The interaction 
between treatments and time was evaluated to 
compare the effectiveness of the two treatments 
in the groups.
Results
Group AL comprised 50 frontal sinuses treat-
ed with BCD and presented a preoperative mean 
SNOT-20 of 60.94 and a mean Lund-MacKay 
frontal sinus CT preoperative grading modified 
according to Zinreich of 1.68. 
Group BL comprised 65 frontal sinuses treated 
with traditional surgery and presented a pre-
operative mean SNOT-20 of 65.54; the mean 
Lund-MacKay frontal sinus CT preoperative 
grading modified according to Zinreich was 1.57.
The statistical comparison between the two 
groups did not show significant differences in 
terms of SNOT-20 or radiological grading (p-val-
ue > 0.05).
Group AS comprised 19 frontal sinuses treated 
with BCD and presented a preoperative mean 
SNOT-20 of 64.79 and a mean Lund-MacKay 
frontal sinus CT preoperative grading modified 
according to Zinreich of 3.10. 
Group BS comprised 14 frontal sinuses treated 
with traditional surgery and presented a pre-
operative mean SNOT-20 of 67.28; the mean 
Lund-MacKay frontal sinus CT preoperative 
grading modified according to Zinreich was 3.07.
Even here the statistical comparison between 
the two groups did not show significant differ-
ences in terms of SNOT-20 or radiological grad-
ing (p-value > 0.05). Postoperative results at 12 
months showed interesting results (Table II):
•  In subgroup AL (BCD in light sinusitis) the 
mean SNOT-20 decreased from 60.94 to 24.60 
while the mean Lund-Mackay CT score in 
frontal sinuses decreased from 1.68 to 0.58. No 
patients were lost at the 12-month follow-up 
and 47 frontal sinuses out of 50 seemed patent 
after one year (94%) assessed with endoscopic 
evaluation.
•  In subgroup BL (Draf 1 in light sinusitis) the 
mean SNOT-20 decreased from 65.54 to 27.54 
while the mean Lund-Mackay CT score in 
frontal sinuses decreased from 1.57 to 0.54. No 
patients were lost at the 12-month follow-up 
and 62 frontal sinuses out of 65 seemed patent 
after one year (95.3 %) assessed with endo-
scopic evaluation.
•  In subgroup AS (BCD in severe sinusitis) the 
mean SNOT-20 decreased from 64.79 to 23.47 
while the mean Lund-Mackay CT score in 
frontal sinuses decreased from 3.10 to 0.53. No 
patients were lost as the 12-month follow-up 
and 18 frontal sinuses out of 19 seemed patent 
after one year (94.7 %) assessed with endo-
scopic evaluation.
•  In subgroup BS (Draf 1 in severe sinusitis) the 
mean SNOT-20 decreased from 67.28 to 30.71 
while the mean Lund-Mackay CT score in 
frontal sinuses decreased from 3.07 to 0.78. No 
patients were lost as the 12-month follow-up 
and 13 frontal sinuses out of 14 seemed patent 
after one year (92.85 %) assessed with endo-
scopic evaluation. The preoperative and post-
operative score of Lund-Mackay CT score in 
AL and AS groups demonstrated a significant 
reduction (p < 0.05), the same happened for 
BL and BS groups (p < 0.05). Comparison be-
tween the two tecniques was not significant in 
light sinusitis (p = 0.30) (Figure 1) and severe 
sinusitis (p = 0.38) (Figure 2).
Comparing preoperative and postoperative 
SNOT-20 score in patients treated with BCD in 
both light and severe sinusitis (AL-AS) we found 
that there was a significant reduction (p < 0.05). 
We found the same result in patients treated 
Table II. Average and standard deviation.
 Lund-Mackay SNOT-20
 Average Standard deviation Average Standard deviation
 Group Pre Post Pre Post Pre Post Pre Post
AL 1.68 0.58 0.47 0.61 60.94 24.6   8.43  8.85
AS 3.10 0.53 0.31 0.61 64.79 23.47  7.59  6.32
BL 1.57 0.54 0.50 0.59 65.54 27.54 10.04  7.43
BS 3.07 0.78 0.27 0.80 67.28 30.71 13.31 10.18
Use of BCD vs. ESS in management of CRS of the frontal sinus: a randomized study
289
with ESS (BL-BS) (p < 0.05). The comparison 
between the two tecniques for light sinusitis (AL 
vs. BL) was not significant (p = 0.42) (Figure 3). 
There is statistical significance in SNOT-20 score 
in the comparison between the two techniques 
in patients with severe sinusitis (AS vs. BL) (p < 
0.05) (Figure 4).
The patency of the frontal recess also observed 
in day-hospital endoscopy was thus similar in 4 
subgroups and there weren’t significative varia-
tions.
The 4 cases of frontal recess obstructed follow-
ing Draf I and the other 4 cases of frontal sinuses 
obstructed after BCD, were subjected to Draf II 
surgery, and in 7 cases anatomical and radiologi-
cal resolution were achieved. We had 1 synechia 
in group BL, which was solved with endoscopic 
surgery. No major complications were observed 
in either group, although minor epistaxis were 
reported occasionally. None of our patients devel-
oped any complication as a result of the BCD pro-
cedure including orbital or skull base dehiscence 
and mucocele formation.
Discussion
CRS of the frontal sinus is a challenging, con-
stantly evolving and extremely controversial con-
dition; CRS may be typically defined as chronic 
inflammation due to an altered environment-host 
interaction at the nose/sinus interface. A particu-
lar biofilm constitution with a different bacterial 
location may increase resistance to standard ther-
apies16. Failures, thus, depend on the relative dif-
ficulty in gaining a therapeutic understanding of 
the various aspects of CRS pathogenesis, which is 
definitely multifactorial. Infectious factors (bac-
terial, including biofilm, viral and fungal), indeed 
coexist with allergic and inflammatory factors 
(affecting the mucosa and the underlying bone), 
and mucociliary clearance deficiency17,18. 
All of these causes determine extreme individ-
ual variability, also in the response to medical or 
surgical treatment19,20.
Tissue reactivity (mucosal and bony) plays a 
very important role in exacerbating CRS; so, for 
the long-term reduction of mucosal inflammation 
Figure 1. Lund-Mackay CT score Balloon vs. Fess light 
sinusitis.
Figure 2. Lund-Mackay CT score Balloon vs. Fess severe 
sinusitis. Figure 4. SNOT-20 score Balloon vs. Fess severe sinusitis.
Figure 3. SNOT-20 score Balloon vs. Fess light sinusitis.
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this is one of the keys for therapeutic success21. In 
fact, many patients with advanced sinus disease 
will never demonstrate a change in their clinical 
and radiological situation because of the nature 
of their biology and for many of them, there is 
no surgery or medicine that will normalize their 
sinus mucosa on imaging. 
ESS restores physiological anatomical sinus 
drainage, opening “the pre-chambers” (Mes-
serklingen)22 or sinus transition space (Setliff)23, 
thus fostering the respect and preservation of 
normal mucosal clearance. This principle is ex-
tremely important especially in the frontal sinus. 
In this area, the preservation of the mucosa is 
crucial in order to prevent a new stenosis of the 
frontal recess and thus, subsequent complex and 
potentially dangerous revision procedures.
The concept of minimally invasive dilation 
technology with a balloon was already utilized 
in several surgical fields24-27 and the application 
in paranasal sinus ostia was described in 1993 by 
Lanza28 with the approvation of the US Food and 
Drug Administration in April 2005, with initial 
safety and feasibility studies reported the follow-
ing year13,29.
BCD is essentially a “transition space instru-
ment”, targeting at first the ethmoidal infun-
dibulum and the frontal recess (the sphenoid 
sinus does not have a real transition space and is 
less involved with inflammatory disease). These 
“spaces” (for Setliff), or “prechambers” (for Mes-
serklinger) are narrow, with a maximum diameter 
of 1.5-2 mm, and even less in many symptomat-
ic patients. The positioning of a submillimeter 
guide-wire and a millimeter balloon catheter into 
these transition spaces can be difficult, but it 
represents the less traumatic way to approach 
this anatomic area. Once in place, the balloon is 
slowly inflated to 10 atm, performing a gradual 
separation of the opposing walls of the transition 
spaces. This forced break of the transition space 
occurs through micro-fractures of the immediate 
peripheral bone (i.e. uncinate process), which 
usually keeps its new position. BCD can be used 
alone as a unique intervention for one or more 
sinuses, or in combination with traditional ESS, 
realizing the so called “hybrid” procedure.
As we said before, it is clear that dilation of 
sinus ostia or their outflow tracts with BCD may 
enhance mucosal preservation, decrease local 
trauma, and restore the patency of the sinuses.
In frontal sinus, the concept behind BCD uti-
lization involves the microfracturing and remod-
eling of bone in the frontal recess, as well. The 
combination of this improved bony and mucosal 
patency, may be enough to restore in an atraumat-
ic way the sinus continued drainage. In addiction, 
the frontal sinuses that failed to show clinical 
and radiological improvement remains available 
to further intervention, be that re-dilation or ad-
vanced endoscopic traditional surgery.
BCD of the frontal sinus outflow is a simple, 
effective and relatively safe procedure, as has 
been shown in several series30-39, even in cases 
of acute frontal sinusitis40, or in revision cases41, 
and can also be performed in the office with local 
anesthesia requirements42-44.
In literature, there is a lot of evidence about 
utility, efficacy and safety of BCD as a potentially 
useful technique that surgeons can use to treat all 
cases of CRS (even in frontal sinuses) in addition 
to traditional endoscopic surgery with multiple 
indications currently reported, and reviews that 
conclude that indications are no different from 
those for performing traditional ESS14,32-34,45-48. 
On the contrary there are some authors that con-
sidered BCD as a technique that can be used only 
in few cases because of the numerous anatomic 
variations of frontal recess and the not common 
practice to obtain a sample for histopathologi-
cal examination during the balloon only proce-
dure49-51.
A recent review52 concludes that the current 
literature does not support the suggestion that 
indications for BCD and ESS are identical, and 
additional researches are needed to determine 
the role for BCD in specific patient populations, 
including revision surgery and CRS with nasal 
polyposis.
Proponents of BCD emphasize that this is a 
less invasive surgical technique in terms of ana-
tomical distortion and mucosal disruption, there-
by minimizing the risk of synechiae formation 
and ostial re-stenosis53,54.
BCD may be also advantageous in the setting 
of anatomic variants such as obstructing type III 
or IV frontal cells that are less accessible to cur-
rent endoscopic instrumentation55, or in the man-
agement of immunocompromised and critical ill 
patients with acute rhinosinusitis also for possible 
dangerous complications39,56.
A potential drawback of BCD is that the in-
strumentation is not reusable between patients, 
and the cost of the disposable instrumentation 
may increase the total cost of the procedure54,57,58.
Additionally, patients with extensive mucosal 
disease, such as polyps, are generally not can-
didates for the current generation of catheters 
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because the goal of treatment in such cases is 
resection of edematous, inflamed mucosa30,55,59.
Other authors affirmed that in case of patients 
with severe disease, polyps or fungal debris, 
mucocele, cystic fibrosis, or facial traumas that 
distort the sinus anatomy, BCD is controindicated 
and conventional ESS is necessary14,60.
Ultimately, there have been few rigorous trials 
comparing risks and benefits of BCD and ESS, and 
as a result of this limited evidence the 2012 EPOS 
guidelines conclude, “overall, the place of these 
systems in the sinus surgeon’s armamentarium 
remains unclear (Evidence Level IV)”55,59,60-62.
Current recommendations, therefore, cite the 
need for additional evidence to clarify the spe-
cific indications, correct utilization, and better 
outcomes of this emerging technology53,61. 
As we can see, the role of BCD is yet unclear, 
and we need additional studies to further evalu-
ate outcomes about the role of BCD in specific 
patient populations, such as those with moderate 
to advanced sinus disease, prior ESS, and nasal 
polyposis52.
In our trial, we divided the population affected 
in two groups, one with light/mild frontal CRS 
and the other with moderate/severe frontal CRS, 
basing on radiological findings at Lund-MacKay 
modified by Zinreich score. Every group was di-
vided in two subgroups, in one we used BCD and 
in the other we used traditional surgery.
The results showed a not statistically signif-
icative difference at one year-control between 
BCD and conventional ESS of the frontal sinus 
in patients with light/mild CRS (p > 0.05) and 
in patients with moderate/severe CRS (p > 0.05), 
studied with Lund-Mackay modified by Zinreich 
score. The same not statistically significative 
difference was observed comparing the results 
of SNOT-20 questionnaire at one year-control in 
the group of light/mild frontal chronic rhinosi-
nusitis (p > 0.05). An interesting result come in-
stead from the evaluation of SNOT-20 in patients 
with moderate/severe chronic rhinosinusitis of 
the frontal sinus after one year of follow-up; we 
noticed indeed, a statistically significant better 
outcome of SNOT-20 score in patients treated 
with BCD vs. those treated with traditional endo-
scopic sinus surgery (p < 0.05).
Furthermore, the rate of patency of frontal os-
tia at the endoscopical evaluation was statistically 
similar between the patients treated with bal-
loon and with traditional surgery in both groups 
(light/mild and moderate/severe CRS) at one-year 
follow-up (p > 0.05). The rate of complicance 
seemed to be the same between BCD and tradi-
tional surgery in light/mild disease and moderate/
severe disease (p > 0.05) demonstrating the simi-
larity between the two techniques. Moreover, we 
observed the same rate of surgical failure (p > 
0.05) between the two procedures and these cases 
were treated with a more radical surgery.
Conclusions 
According to current literature, the role of 
BCD in sinus surgery is yet unclear. We noticed 
that specific recommendations and indications of 
BCD use in more-advanced frontal sinus disease 
(defined as radiological almost total opacification 
of the frontal sinus) have not been previously 
addressed. Analyzing our data, we can say that 
balloon catheter dilation and traditional endo-
scopic surgery (Draf 1 in ESS) are two alterna-
tive weapons in the baggage of every endoscopic 
surgeon, even because they present similar out-
comes, safeness, and effectiveness both in light/
mild and moderate/severe chronic rhinosinusitis 
of the frontal sinus. An interesting result of our 
study was the statistically significant better out-
come of SNOT-20 score in patients that under-
went BCD of frontal sinus for a moderate/severe 
CRS, compared to those that underwent a tradi-
tional endoscopic sinus surgery. Even if this test 
is completely subjective and is based only on the 
symptoms reported by the patients, if these re-
sults will be confirmed by other studies, it could 
be possible to find some indications to the use of 
BCD in specific pathological variety of chronic 
rhinosinusitis.
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